Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Nutr Neurosci ; 25(3): 581-592, 2022 Mar.
Article in English | MEDLINE | ID: mdl-32558624

ABSTRACT

Background: Interoceptive properties of food may influence emotional state and its neural basis, as shown for fatty acids but remains unstudied for carbohydrates.Objectives: To study the effects of fructose and its interaction with sad emotion on brain activity in homeostatic and hedonic regions and investigate whether gut hormone responses can explain effects.Design: In 15 healthy subjects, brain activity for 40min after intragastric infusion of fructose (25g) or water was recorded using a cross-over pharmacological magnetic resonance imaging (phMRI) paradigm. Sad or neutral emotional states were induced by classical music and emotional facial expressions. Emotional state was assessed using the Self-Assessment Manikin. Blood samples were taken to assess gut hormone levels. Brain responses to fructose versus placebo, sad versus neutral emotion, and their interaction were analyzed over time in a single mask of a priori defined regions of interest at a voxel-level threshold of pFWEcorrected <0.05. Effects on emotion and hormones were tested using linear mixed models.Results: No main effects of fructose, emotion, or fructose-by-emotion interaction on emotional ratings were observed. Main effects of fructose, emotion and aninteraction effect were found on brain activity (medulla, midbrain, hypothalamus, basal ganglia, anterior insula, orbitofrontal cortex, anterior cingulate cortex and amygdala). An increase in circulating GLP-1 after fructose in neutral emotion was abolished during sad emotion (fructose-by-emotion-by-time, p=0.041). Ghrelin levels were higher in sad emotion (time-by-emotion, p=0.037).Conclusions: Emotional state interacts with brain and endocrine responses to intragastric infusion of 25 g of fructose, however such an effect was not found at behavioral level.Trial registration: ClinicalTrials.gov identifier: NCT02946983.


Subject(s)
Brain , Fructose , Emotions/physiology , Homeostasis , Humans , Magnetic Resonance Imaging
2.
Psychoneuroendocrinology ; 108: 43-52, 2019 10.
Article in English | MEDLINE | ID: mdl-31226660

ABSTRACT

BACKGROUND: Subliminal intragastric fatty acid infusion attenuates subjective and brain responses to negative emotion induction. However, the underlying gut-brain signaling mechanisms remain unclear, and it is unknown whether such effect equally applies to positive emotion. OBJECTIVE: We aimed to investigate the interaction between fatty acid-induced gut-brain signaling and subjective responses to positive emotion, and the potential mediational role of gastrointestinal (GI) hormones. DESIGN: Twelve fasting healthy women underwent intragastric infusion of 2.5 g lauric acid or saline, after which either positive or neutral emotion was induced for 30 min, in 4 separate visits. Appetite-related sensations, subjective emotional state, and GI hormones were measured at baseline and every 10 min after infusion. Heart rate variability was measured at baseline and at t = 20-30 min to quantify vagal tone (root mean square of successive differences, RMSSD), and sympathovagal balance (low frequency to high frequency ratio, LF/HF). RESULTS: Fatty acid infusion did not influence appetite-related sensations (as expected), nor emotional state ratings (contrary to expectations). As anticipated, fatty acid stimulated release of CCK at t = 20-40 min (p < 0.001), and GLP1 at t = 30-40 min (p < 0.001), but not PYY. Interestingly, positive emotion induction suppressed plasma octanoylated ghrelin at t = 20-40 min (p = 0.020). Further, both positive emotion and fatty acid attenuated RMSSD (p = 0.012 & 0.0073, respectively). Positive emotion attenuated LF/HF after fatty acid (p = 0.0006), but raised LF/HF after saline (p = 0.004). CONCLUSIONS: Subliminal fatty acid did not influence subjective responses to positive emotion induction. However, positive emotion induction suppressed octanoylated ghrelin release. Moreover, both positive emotion and subliminal fatty acid decreased cardiac vagal tone. Further, the fatty acid reversed the effect of positive emotion on sympathovagal balance.


Subject(s)
Appetite/physiology , Emotions/drug effects , Lauric Acids/pharmacology , Adult , Brain , Cholecystokinin/analysis , Cholecystokinin/blood , Emotions/physiology , Fasting , Fatty Acids/pharmacology , Female , Ghrelin/analysis , Ghrelin/blood , Glucagon-Like Peptide 1/analysis , Glucagon-Like Peptide 1/blood , Healthy Volunteers , Heart Rate/physiology , Humans , Intubation, Gastrointestinal/methods , Vagus Nerve , Young Adult
3.
Nutr Neurosci ; 22(12): 850-862, 2019 Dec.
Article in English | MEDLINE | ID: mdl-29607741

ABSTRACT

Objectives: Intragastric bitter tastants may decrease appetite and food intake. We aimed to investigate the gut-brain signaling and brain mechanisms underlying these effects.Methods: Brain responses to intragastric quinine-hydrochloride (QHCl, 10 µmol/kg) or placebo infusion were recorded using functional magnetic resonance imaging in 15 healthy women. Appetite-related sensations, plasma levels of gastrointestinal hormones and hedonic food intake (ad libitum drink test) were assessed.Results: Lower octanoylated ghrelin (P<0.04), total ghrelin (P<0.01), and motilin (P<0.01) plasma levels were found after QHCl administration, along with lower prospective food consumption ratings (P<0.02) and hedonic food intake (P<0.05). QHCl increased neural activity in the hypothalamus and hedonic (anterior insula, putamen, caudate, pallidum, amygdala, anterior cingulate cortex, orbitofrontal cortex, midbrain) regions, but decreased activity in the homeostatic medulla (all pFWE-corrected<0.05). Differential brain responses to QHCl versus placebo covaried with subjective and hormonal responses and predicted differences in hedonic food intake.Discussion: Intragastric QHCl decreases prospective and actual food intake in healthy women by interfering with homeostatic and hedonic brain circuits in a ghrelin- and motilin-mediated fashion. These findings suggest a potential of bitter tastants to reduce appetite and food intake, through the gut-brain axis.


Subject(s)
Appetite/drug effects , Brain/physiology , Eating/drug effects , Gastrointestinal Tract/physiology , Quinine/administration & dosage , Adult , Appetite/physiology , Brain/drug effects , Cross-Over Studies , Female , Gastrointestinal Tract/drug effects , Ghrelin/blood , Humans , Intubation, Gastrointestinal , Magnetic Resonance Imaging , Motilin/blood , Placebos , Signal Transduction , Single-Blind Method , Stomach/drug effects
4.
Ann N Y Acad Sci ; 1428(1): 129-150, 2018 09.
Article in English | MEDLINE | ID: mdl-30255954

ABSTRACT

Over the past few years, scientific interest in the gut-brain axis (i.e., the bidirectional communication system between the gastrointestinal tract and the brain) has exploded, mostly due to the identification of the gut microbiota as a novel key player in this communication. However, important progress has also been made in other aspects of gut-brain axis research, which has been relatively underemphasized in the review literature. Therefore, in this review, we provide a comprehensive, although not exhaustive, overview of recent research on the functional neuroanatomy of the gut-brain axis and its relevance toward the multidisciplinary field of health neuroscience, excluding studies on the role of the gut microbiota. More specifically, we first focus on irritable bowel syndrome, after which we outline recent findings on the role of the gut-brain axis in appetite and feeding regulation, primarily focusing on the impact of subliminal nutrient-related gut-brain signals. We conclude by providing future perspectives to facilitate translation of the findings from gut-brain axis neuroscientific research to clinical applications in these domains.


Subject(s)
Appetite Regulation/physiology , Gastrointestinal Diseases/physiopathology , Gastrointestinal Tract/physiopathology , Anticipation, Psychological/physiology , Autonomic Nervous System/physiology , Blood Glucose/physiology , Fear/physiology , Feeding Behavior/physiology , Functional Neuroimaging , Gastrointestinal Diseases/psychology , Gastrointestinal Tract/innervation , Humans , Hyperalgesia/physiopathology , Hyperalgesia/psychology , Interoception/physiology , Irritable Bowel Syndrome/physiopathology , Irritable Bowel Syndrome/psychology , Life Change Events , Nerve Net/physiology , Neural Pathways/physiology , Neurosecretory Systems/physiology , Nutrients/pharmacology , Obesity/etiology , Obesity/physiopathology , Obesity/psychology , Pain Perception/physiology , Reward , Stress, Physiological/physiology , Visceral Pain/physiopathology , Visceral Pain/psychology
5.
Sci Rep ; 8(1): 1819, 2018 01 29.
Article in English | MEDLINE | ID: mdl-29379095

ABSTRACT

The motilin agonist, erythromycin, induces gastric phase III of the migrating motor complex, which in turn generates hunger peaks. To identify the brain mechanisms underlying these orexigenic effects, 14 healthy women participated in a randomized, placebo-controlled crossover study. Functional magnetic resonance brain images were acquired for 50 minutes interprandially. Intravenous infusion of erythromycin (40 mg) or saline started 10 minutes after the start of scanning. Blood samples (for glucose and hormone levels) and hunger ratings were collected at fixed timepoints. Thirteen volunteers completed the study, without any adverse events. Brain regions involved in homeostatic and hedonic control of appetite and food intake responded to erythromycin, including pregenual anterior cingulate cortex, anterior insula cortex, orbitofrontal cortex, amygdala, caudate, pallidum and putamen bilaterally, right accumbens, hypothalamus, and midbrain. Octanoylated ghrelin levels decreased, whereas both glucose and insulin increased after erythromycin. Hunger were higher after erythromycin, and these differences covaried with the brain response in most of the abovementioned regions. The motilin agonist erythromycin increases hunger by modulating neurocircuitry related to homeostatic and hedonic control of appetite and feeding. These results confirm recent behavioural findings identifying motilin as a key orexigenic hormone in humans, and identify the brain mechanisms underlying its effect.


Subject(s)
Brain/drug effects , Erythromycin/therapeutic use , Homeostasis/drug effects , Hunger/drug effects , Motilin/agonists , Adult , Appetite/drug effects , Brain/metabolism , Cross-Over Studies , Eating/drug effects , Female , Ghrelin/metabolism , Glucose/metabolism , Humans , Insulin/metabolism , Women's Health
6.
J Pain ; 18(10): 1197-1208, 2017 10.
Article in English | MEDLINE | ID: mdl-28533182

ABSTRACT

A growing body of research has identified fear of visceral sensations as a potential mechanism in the development and maintenance of visceral pain disorders. However, the extent to which such learned fear affects visceroception remains unclear. To address this question, we used a differential fear conditioning paradigm with nonpainful esophageal balloon distensions of 2 different intensities as conditioning stimuli (CSs). The experiment comprised of preacquisition, acquisition, and postacquisition phases during which participants categorized the CSs with respect to their intensity. The CS+ was always followed by a painful electrical stimulus (unconditioned stimulus) during the acquisition phase and in 60% of the trials during postacquisition. The second stimulus (CS-) was never associated with pain. Analyses of galvanic skin and startle eyeblink responses as physiological markers of successful conditioning showed increased fear responses to the CS+ compared with the CS-, but only in the group with the low-intensity stimulus as CS+. Computational modeling of response times and response accuracies revealed that differential fear learning affected perceptual decision-making about the intensities of visceral sensations such that sensations were more likely to be categorized as more intense. These results suggest that associative learning might indeed contribute to visceral hypersensitivity in functional gastrointestinal disorders. PERSPECTIVE: This study shows that associative fear learning biases intensity judgements of visceral sensations toward perceiving such sensations as more intense. Learning-induced alterations in visceroception might therefore contribute to the development or maintenance of visceral pain.


Subject(s)
Fear , Learning , Pain Perception , Visceral Pain/psychology , Acoustic Stimulation , Analysis of Variance , Computer Simulation , Decision Making , Electric Stimulation , Esophagus , Female , Humans , Judgment , Male , Psychological Tests , Reaction Time , Reflex, Startle , Software , Young Adult
7.
United European Gastroenterol J ; 3(2): 160-5, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25922675

ABSTRACT

The avoidance of wheat- and gluten-containing products is a worldwide phenomenon. While coeliac disease is well-established, much remains unknown about whether gluten can be a trigger of gastrointestinal and/or extra-intestinal symptoms in patients without coeliac disease. In this article, we discuss the latest scientific evidence and our current understanding for the possible mechanisms of this largely ambiguous group, termed 'non-coeliac gluten sensitive' (NCGS). We can conclude that NCGS should be regarded as an independent disease outside of coeliac disease and wheat allergy, and that the number of patients affected is likely to be limited. Many questions remain unanswered and it needs to be verified whether the elimination of dietary gluten alone is sufficient for the control of symptoms, and to understand the overlap with other components of wheat.

SELECTION OF CITATIONS
SEARCH DETAIL
...